These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 319874)

  • 21. Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci.
    Sanders CC; Sanders WE; Harrowe DJ
    Infect Immun; 1976 Mar; 13(3):808-12. PubMed ID: 818017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Throat Carriage Rate and Antimicrobial Resistance of
    Delpech G; Sparo M; Baldaccini B; Pourcel G; Lissarrague S; García Allende L
    J Prev Med Public Health; 2017 Mar; 50(2):127-132. PubMed ID: 28372355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of tet(M), tet(O) and tet(S) in tetracycline/minocycline-resistant Streptococcus pyogenes bacteraemia isolates.
    Hammerum AM; Nielsen HU; Agersø Y; Ekelund K; Frimodt-Moller N
    J Antimicrob Chemother; 2004 Jan; 53(1):118-9. PubMed ID: 14657081
    [No Abstract]   [Full Text] [Related]  

  • 24. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.
    Sanders E; Foster MT; Scott D
    N Engl J Med; 1968 Mar; 278(10):538-40. PubMed ID: 4966066
    [No Abstract]   [Full Text] [Related]  

  • 25. [Streptococcus pyogenes group A--sensitivity to chemical preparations in vitro].
    Výmola F; Jedlicková Z
    Cas Lek Cesk; 1972 Mar; 111(13):292-4. PubMed ID: 4552005
    [No Abstract]   [Full Text] [Related]  

  • 26. Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance.
    Brenciani A; Ojo KK; Monachetti A; Menzo S; Roberts MC; Varaldo PE; Giovanetti E
    J Antimicrob Chemother; 2004 Dec; 54(6):991-8. PubMed ID: 15563518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antibacterial activity in vitro of a new rifamycin: rifamide].
    Monnier J; Bourse R
    Pathol Biol; 1968 Oct; 16(19):901-8. PubMed ID: 4972879
    [No Abstract]   [Full Text] [Related]  

  • 28. Trends in antimicrobial resistance patterns of Group A streptococci, molecular basis and implications.
    Abraham T; Sistla S
    Indian J Med Microbiol; 2018; 36(2):186-191. PubMed ID: 30084408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia.
    Pavlovic L; Grego E; Sipetic-Grujicic S
    Jpn J Infect Dis; 2010 Jul; 63(4):275-6. PubMed ID: 20657068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative and qualitative determinations of the combined effect of tetracycline and oleandomycin. I. In vitro effect.
    Tone J; Niki K; Maeda H; Ihara I; Kawakami M
    Jpn J Antibiot; 1976 May; 29(5):559-70. PubMed ID: 6805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial resistance in Streptococcus pyogenes (GAS) from healthy carriers and tonsillitis patients and association with antibacterial sale in the Faroe Islands.
    Magnussen MD; Gaini S; Gislason H; Kristinsson KG
    APMIS; 2016 Apr; 124(4):327-32. PubMed ID: 26833774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotic sensitivity of beta-hemolytic Streptococcus group A on a new nutrient medium for the cultivation of streptococci].
    Givental' NI; Krasil'nikova OA; Osmanov SK; Bogdanova LF; Vorob'eva LS
    Antibiotiki; 1983 May; 28(5):325-31. PubMed ID: 6349518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical anaerobic forms of Streptococcus pyogenes associated with tetracycline resistance.
    LOWBURY EJ; HURST L
    J Clin Pathol; 1956 Feb; 9(1):59-65. PubMed ID: 13306794
    [No Abstract]   [Full Text] [Related]  

  • 34. [Microbiological and chemotherapeutic study of the antibiotic mutabilicin].
    Perrova MA; Shneerson AN; Tebiakina AE; Navashin SM; Braginskaia PS
    Antibiotiki; 1967 May; 12(5):404-6. PubMed ID: 4385808
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and microbiological characteristics of severe infections caused by group A streptococci].
    Hupková H; Zaborská M; Sisovský V; Babál P; Simaljaková M; Koren M; Reis R; Kozáková J
    Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):164-7. PubMed ID: 25642472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Patterns of susceptibility in group A streptococci].
    Betriu C; Gómez M; Sánchez A; Cruceyra A; Romero J; Picazo JJ
    Enferm Infecc Microbiol Clin; 1994 May; 12(5):273-4. PubMed ID: 8049297
    [No Abstract]   [Full Text] [Related]  

  • 37. [Transition of drug sensitivity of group A streptococci in the last 6 years (1967-72)].
    Okubo N; Kashiwagi Y; Shibata M; Tokue S
    Kansenshogaku Zasshi; 1973 Dec; 47(12):506-9. PubMed ID: 4208597
    [No Abstract]   [Full Text] [Related]  

  • 38. Prophage association of mef(A) elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes.
    Giovanetti E; Brenciani A; Vecchi M; Manzin A; Varaldo PE
    J Antimicrob Chemother; 2005 Apr; 55(4):445-51. PubMed ID: 15772148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sensitivity of groups A, B and C beta hemolytic streptococci to antibiotics].
    González-Lama Z; González JJ; Tejedor MT; Lupiola P
    Rev Esp Quimioter; 1999 Sep; 12(3):215-9. PubMed ID: 10878511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic resistance of revertant cultures of Streptococcus group A and of unclassified streptococci isolated from the blood of rheumatism patients].
    Vul'fovich IuV; Krasil'nikova OIa; Konstantinova ND; Gamova NA
    Antibiot Med Biotekhnol; 1986 Aug; 31(8):628-33. PubMed ID: 3532941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.